Citation only
via OpenAlex
Novel therapies for sarcopenia: ameliorating age-related changes in skeletal muscle
Expert Opinion on Therapeutic Patents · 2002 · ▲ 14 citations
Abstract
Among the most serious consequences of ageing are its effects on skeletal muscle structure and function. Ageing is associated with a progressive loss of muscle mass (sarcopenia) motor function, a slowing of muscle movements and a decline in muscle strength. These age-related changes in muscle properties contribute to the gradual loss of functional independence and the increased incidence of fall-related injuries in the elderly. Progressive muscle fibre denervation, the loss of motor units and subsequent motor unit remodelling have been implicated as mechanisms responsible for these deleterious effects of ageing on skeletal muscle, especially the loss of force and power output. However, the age-related reduction in the speed of contraction has been reported to occur before the onset of severe muscle wasting, indicating that age-related changes intrinsic to skeletal muscle fibres cannot be excluded. Even in the absence of disease, muscles atrophy and become functionally weaker with age. From a public health perspective, sarcopenia has widespread clinical implications. Diminished muscle mass and functional strength with age increases the risk of injury from sudden falls and increases the dependence on the frail elderly for assistance in accomplishing even the most basic tasks required for independent living, including the maintenance of personal hygiene, feeding and recreational pursuits, leading to an inability to perform even simple activities required for daily living. Research into ageing and muscle function is of increasing importance to the community as the ageing population continues to escalate. It is generally agreed that such age-related changes in skeletal muscle structure and function are inevitable, although debate exists as to whether these intrinsic changes are immutable or reversible. Clearly, there is a profound need for therapeutic intervention strategies that aim to slow the effects of ageing on muscle function and/or restore muscle size and strength in the frail elderly so as to improve or maintain their quality of life. This review examines recent (1998 - 2001) patents on novel strategies for ameliorating the effects of ageing on muscle structure and function.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1517/13543776.12.1.11
- Canonical
- link ↗
- Fetched
- 2026-10-17 MST
Cite this
APA
Lynch, G.S. (2002). Novel therapies for sarcopenia: ameliorating age-related changes in skeletal muscle. <em>Expert Opinion on Therapeutic Patents</em>. https://doi.org/10.1517/13543776.12.1.11
Vancouver
Lynch GS. Novel therapies for sarcopenia: ameliorating age-related changes in skeletal muscle. Expert Opinion on Therapeutic Patents. 2002. doi:10.1517/13543776.12.1.11.
BibTeX
@article{gordon2002Novelt,
title = {Novel therapies for sarcopenia: ameliorating age-related changes in skeletal muscle},
author = {Gordon Stuart Lynch},
journal = {Expert Opinion on Therapeutic Patents},
year = {2002},
doi = {10.1517/13543776.12.1.11},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Internal Medicine Journal 2004
Citation only
Tackling Australia's future health problems: developing strategies to combat sarcopenia − age‐related muscle wasting and weakness
Expert Opinion on Emerging Drugs 2004
Citation only
Emerging drugs for sarcopenia: age-related muscle wasting
Expert Opinion on Therapeutic Patents 2004
Citation only
Update on therapies for sarcopenia: novel approaches for age-related muscle wasting and weakness
PubMed 2008
Preprint
Aging and sarcopenia.
Expert Opinion on Emerging Drugs 2008
Citation only
Update on emerging drugs for sarcopenia – age-related muscle wasting
Cell Death and Disease 2023
Open access · CC-BY